Evidence map›Paper›PMID 37033771›Full record

ArticleBrain, behavior, & immunity - health2023

Inflammation and severity of depressive symptoms in physically active individuals after COVID-19 - An exploratory immunopsychological study investigating the effect of inflammation on depressive symptom severity.

Lynn Matits, Moritz Munk, Daniel Alexander Bizjak, Iris-Tatjana Kolassa, Sarah Karrasch, Shirin Vollrath, Achim Jerg, Jürgen Michael Steinacker

Open access · goldAbstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lynn MatitsDivision of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.
Moritz MunkDivision of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.
Daniel Alexander BizjakDivision of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.
Iris-Tatjana KolassaClinical & Biological Psychology, Institute of Psychology and Education, Ulm University, Ulm, Germany.
Sarah KarraschClinical & Biological Psychology, Institute of Psychology and Education, Ulm University, Ulm, Germany.
Shirin VollrathDivision of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.
Achim JergDivision of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.
Jürgen Michael SteinackerDivision of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.
University Hospital Ulm · DEUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: SARS-CoV-2 infection is a risk factor for the development of depressive symptoms such as lack of energy, loss of interest, and depressed mood. Inflammatory processes might underline this association. The aim of this study was to investigate the association between inflammatory markers and the severity of depression after SARS-CoV-2 infection and the predictive effect of inflammatory markers on the severity of depressive symptoms. Lifestyle factors and lifestyle-related diseases can influence inflammation and depressive symptoms. As these lifestyle factors and lifestyle-related diseases are less common in physically active individuals, they are a suitable population for investigating this research question. Methods: We investigated 61 at least moderate physically active individuals on average ∼6 months ( Results: Concentrations of KYN were negatively related to the severity of depressive symptoms at t Conclusions: KYN, LBP and LMR might be useful as a predictive factor of depressive symptoms in physically active individuals after SARS-CoV-2 infection. While the results for KYN confirm the current scientific evidence, our results highlight the importance of the innovative inflammatory markers LMR and LBP. LMR and LBP might be interesting targets for predicting the development of depressive symptoms in SARS-CoV-2 infected populations and should be further investigated in future studies.

Indexed as

CytokinesDepressivenessInflammatory cell ratiosKynurenineSARS-CoV-2

Identifiers

PMID37033771
PMCPMC10035808
OpenAlexW4360603324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.